B. Cicek Et Al. , "Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries," Pharmaceuticals , vol.16, no.2, 2023
Cicek, B. Et Al. 2023. Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries. Pharmaceuticals , vol.16, no.2 .
Cicek, B., Hacimuftuoglu, A., Kuzucu, M., Cetin, A., Yeni, Y., Genc, S., ... Yildirim, S.(2023). Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries. Pharmaceuticals , vol.16, no.2.
Cicek, Betul Et Al. "Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries," Pharmaceuticals , vol.16, no.2, 2023
Cicek, Betul Et Al. "Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries." Pharmaceuticals , vol.16, no.2, 2023
Cicek, B. Et Al. (2023) . "Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries." Pharmaceuticals , vol.16, no.2.
@article{article, author={Betul Cicek Et Al. }, title={Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries}, journal={Pharmaceuticals}, year=2023}